BCK Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

BCK Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-28,107	Closed	-$1.08M	–	101
2023 Q2	$1.08M	Buy	+28,107	New	+$722K	0.82%	20

BCK Capital Management's KDNY Position: Q3 2023 in Review

BCK Capital Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 28,107 shares — an estimated $1.08M sold.

BCK Capital Management first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $1.08M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

BCK Capital Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
BCK Capital Management sold 28,107 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.08M.
BCK Capital Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
BCK Capital Management's Chinook Therapeutics, Inc. Common Stock position peaked at $1.08M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on BCK Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.